Product Details
Piperacillin/Tazobactam powder for Inj.
Piperacillin Sodium + Tazobactam Sodium4 g + 500 mg
Powder for Injection
4.5 g Vial Pack
DIN/PIN/NPN
02370174
Manufacturer
Teva Canada Limited
Formulary Listing Date
2012-07-27
Unit Price
20.2700
Amount MOH Pays
20.2700
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
J01CR05
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02170809 | Tazocin | NA | NA |
| 02370174 | Piperacillin/Tazobactam powder for Inj. | 20.2700 | 20.2700 |
| 02401339 | Piperacillin and Tazobactam for Inj | 20.2700 | 20.2700 |
| 02402084 | Piperacillin & Tazobactam for Injection | 20.2700 | 20.2700 |
| 02362635 | Piperacillin & Tazobactam for Injection | 20.2700 | 20.2700 |
| 02308460 | Piperacillin & Tazobactam for Injection | 20.2700 | 20.2700 |
LU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |